This trial studies how a medicine called Ritlecitinib affects children (6-12 yrs) with alopecia areata (scalp hair loss) over 10 weeks, with 20mg daily doses & blood tests.
- Alopecia Areata
1 Primary · 15 Secondary · Reporting Duration: 0 (pre-dose), 0.5, 1, 3 and 8 hours post-dose on Day 7
Awards & Highlights
1 Treatment Group
Ritlecitinib 20 mg
1 of 1
15 Total Participants · 1 Treatment Group
Primary Treatment: Ritlecitinib 20 mg · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 6 - 11 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
|Texas Dermatology and Laser Specialists||100.0%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
How many prior treatments have patients received?
Frequently Asked Questions
Are individuals aged 70 and younger admissible for this research program?
"This medical study will consider children between the ages of 6 and 11 to be eligible participants." - Anonymous Online Contributor
Is Ritlecitinib 20 mg a safe treatment option for individuals?
"Our estimations gave Ritlecitinib 20 mg a score of 1 due to its Phase 1 trial status, implying limited evidence regarding efficacy and safety." - Anonymous Online Contributor
Does this research endeavor need additional participants?
"Clinicaltrials.gov suggests that this trial is currently seeking volunteers; the entry was initially posted on March 2nd, 2023 and revised on March 14th of the same year." - Anonymous Online Contributor
How many individuals are being administered treatments within this clinical experiment?
"Correct. Data hosted on clinicaltrials.gov verifies that this medical study, which was first posted on March 2nd 2023, is actively recruiting people to take part in the trial. A total of 15 participants are sought from 5 separate medical centres." - Anonymous Online Contributor
To whom is this research opportunity available?
"To be eligible for participation in this trial, individuals should possess alopecia areata and be between the ages of 6 to 11. Currently, approximately 15 participants are sought after." - Anonymous Online Contributor
How many physical locations can one access this research?
"There are 5 active study locations for this clinical trial, including the Pediatric Skin Research LLC in Coral Gables, Dawes Fretzin Clinical Research Group LLC in Indianapolis, and Vital Prospects Clinical Research Institute PC in Tulsa. Moreover, there are an additional five sites hosting this research." - Anonymous Online Contributor